Polypoid Bladder Lesions Are More Likely Malignant Than Benign
Polypoid lesions on the lateral bladder wall should be presumed malignant until proven otherwise by histopathologic examination, as urothelial carcinoma is by far the most common bladder pathology and papillary urothelial carcinomas frequently present with polypoid morphology.
Why Malignancy Must Be the Primary Concern
The lateral bladder wall is a common site for urothelial carcinoma, which accounts for >90% of bladder tumors in the United States and Europe 1. Papillary urothelial carcinomas—which include both low-grade and high-grade malignancies—characteristically present as polypoid masses 1. The NCCN guidelines emphasize that papillary lesions may be benign (urothelial papilloma, inverted papilloma) or malignant (papillary urothelial neoplasms of low malignant potential and papillary urothelial carcinomas), but the malignant forms vastly outnumber benign variants 1.
Diagnostic Approach
Cystoscopy with biopsy/TURBT is mandatory for definitive diagnosis, as imaging cannot reliably distinguish benign from malignant polypoid lesions:
- CTU has 87% sensitivity for bladder cancer but may miss small or flat lesions 2. It demonstrated 91% diagnostic accuracy overall but had false-negatives, particularly with carcinoma in situ 2
- Imaging findings are unreliable: Even advanced imaging features like wall thickening and perivesical fat stranding can occur with benign polypoid cystitis, mimicking invasive carcinoma 3
- DWI-MRI shows promise with 100% sensitivity and 93.65% accuracy for malignancy, with malignant lesions showing lower ADC values (1.07 vs 1.80 × 10⁻³ mm²/s for benign) 4, but this still requires histologic confirmation
Benign Polypoid Lesions: The Rare Exceptions
While benign polypoid lesions exist, they are uncommon and have specific clinical contexts:
- Polypoid cystitis: Associated with chronic catheterization, younger age, obstructive LUTS without hematuria, and no family history of bladder cancer 5. However, this can radiologically mimic advanced carcinoma 3
- Mullerianosis: Extremely rare (<20 reported cases), affects fertile-age women, typically involves bladder dome/posterior wall, and presents with cyclical symptoms 6
Critical Pitfalls to Avoid
- Never assume a polypoid bladder lesion is benign based on imaging alone—even benign polypoid cystitis can show perivesical fat stranding mimicking T3 disease 3
- Young age does not exclude malignancy—while benign lesions are more common in younger patients without risk factors, histologic confirmation is still mandatory 5
- Polypoid morphology on imaging (CTU showing 26/38 lesions as polypoid) cannot differentiate benign from malignant 7
Management Algorithm
For any polypoid lateral bladder wall lesion:
- Obtain CTU to evaluate for synchronous upper tract disease (2-4% concurrent UTUC risk) 2
- Perform cystoscopy with complete TURBT of the lesion 1
- Send all tissue for histopathologic evaluation with grading per 2022 WHO Classification 1
- Document any subtype histology, as this affects prognosis and treatment intensity 1
The only way to definitively exclude malignancy is through adequate tissue sampling and expert pathologic review—clinical and radiologic features alone are insufficient given the high prevalence of urothelial carcinoma and the ability of benign lesions to mimic cancer.